Find More Contacts for Ocera Therapeutics
Protected Content
Non-Management
1 email found
View contacts for Ocera Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Phone Number 650-475-0158

Ocera is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need.

Ocera's HE clinical development efforts include a recently completed Phase 2b clinical trial, STOP-HE, which evaluated the safety and

efficacy of intravenously-administered OCR-002 in resolving neurocognitive symptoms of acute HE in hospitalized patients with elevated ammonia. Ocera is preparing to meet with the FDA later this year to review the IV program and discuss potential development paths forward.

Lists Featuring This Company

Closed Palo Alto Companies
847 Number of Organizations â€¢ $7.3B Total Funding Amount â€¢ 1,520 Number of Investors
Acquired Silicon Valley Companies
4,289 Number of Organizations â€¢ $129.7B Total Funding Amount â€¢ 13,861 Number of Investors
Silicon Valley Companies that Exited
4,657 Number of Organizations â€¢ $378.8B Total Funding Amount â€¢ 16,160 Number of Investors
Closed Therapeutics Companies
642 Number of Organizations â€¢ $23.5B Total Funding Amount â€¢ 1,651 Number of Investors
Ocera Therapeutics was acquired by Mallinckrodt for $42M on Nov 2, 2017. This deal was done in Cash.

Frequently Asked Questions

Where is Ocera Therapeutics's headquarters? Ocera Therapeutics is located in Palo Alto, California, United States.Who invested in Ocera Therapeutics? Ocera Therapeutics has 21 investors including Silicon Valley Bank and Greenspring Associates.How much funding has Ocera Therapeutics raised to date? Ocera Therapeutics has raised .When was the last funding round for Ocera Therapeutics? Ocera Therapeutics closed its last funding round on Aug 3, 2015 from a Post-IPO Debt round.Who are Ocera Therapeutics's competitors? Alternatives and possible competitors to Ocera Therapeutics may include CytokineticsReata Pharmaceuticals, and Aclaris Therapeutics.